These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9069559)

  • 21. [Antimicrobial activity of amoxicillin versus amoxicillin/clavulanic acids. In vitro study against S aureus, H influenzae and A baumanii strains].
    Trucco O; Prado V; Garreaud C; Paya E
    Rev Med Chil; 1993 Aug; 121(8):916-22. PubMed ID: 8296100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.
    Wise R; Andrews JM; Bedford KA
    J Antimicrob Chemother; 1980 Mar; 6(2):197-206. PubMed ID: 6247316
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of clavulanic acid on the susceptibility to amoxycillin of beta-lactamase producing strains of H. influenzae using different inoculum sizes.
    Van Klingeren B; Dessens-Kroon M
    J Antimicrob Chemother; 1979 May; 5(3):322-3. PubMed ID: 314442
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic interaction of amoxycillin and clavulanic acid against 132 beta-lactamase positive Haemophilus isolates: a comparison with some other oral agents.
    Lapointe JR; Lavallée C
    J Antimicrob Chemother; 1987 Jan; 19(1):49-58. PubMed ID: 3494009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
    Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
    J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
    Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
    Gaviraghi G; Perboni A; Tamburini B; Xerri L; Salvatori A; Spadoni G; Tarzia G
    Farmaco; 1996 Jul; 51(7):535-8. PubMed ID: 8765676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of clavulanic acid and beta-lactamase on phagocytosis of Staphylococcus aureus.
    Martínez-Martínez L; Pascual A; Conejo MC; Perea EJ
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):783-4. PubMed ID: 2261924
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative activity of oral beta-lactam antibiotics at clinically achievable levels against Haemophilus influenzae serotype b.
    Doit C; Conort-Valentin S; Sanchez C; Mariani-Kurkdjian P; Bingen E
    J Antimicrob Chemother; 1994 Feb; 33(2):363-4. PubMed ID: 8182027
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
    de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
    Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of beta-lactamase in expression of resistance by methicillin-resistant Staphylococcus aureus.
    Boyce JM; Medeiros AA
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1426-8. PubMed ID: 3499863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of restoration of sensitivities of resistant Staphylococcus aureus isolates by using cefuroxime and clavulanic acid in combination.
    Jalil A; Niazi ID; Khan SU
    J Ayub Med Coll Abbottabad; 2008; 20(2):28-30. PubMed ID: 19385452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ; Jin YF; Turner HL
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.
    Hoover J; Lewandowski T; Straub RJ; Novick SJ; DeMarsh P; Aubart K; Rittenhouse S; Zalacain M
    Antimicrob Agents Chemother; 2016 Jan; 60(1):180-9. PubMed ID: 26482300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fixed or variable concentrations of beta-lactamase inhibitors in in-vitro tests?
    Greenwood D
    J Antimicrob Chemother; 1996 Jul; 38(1):17-20. PubMed ID: 8858452
    [No Abstract]   [Full Text] [Related]  

  • 37. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro demonstration of a true post-beta-lactamases inhibitor effect (PLIE) of clavulanic acid on Klebsiella pneumoniae and Haemophilus influenzae].
    Murbach V; Dhoyen N; Linger L; Monteil H; Jehl F
    Pathol Biol (Paris); 1999 May; 47(5):462-8. PubMed ID: 10418019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activity of temocillin against Enterobacteriaceae, Pseudomonas and Haemophilus influenzae.
    Chen HY; Williams JD
    Drugs; 1985; 29 Suppl 5():85-90. PubMed ID: 3875475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.